Saba Capital Management, L.P. Ibere Pharmaceuticals Transaction History

Saba Capital Management, L.P.

  • $5.92 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$9.93 - $10.09 $265,131 - $269,403
26,700 Added 8.12%
355,704 $3.59 Million
Q3 2022

Nov 14, 2022
BUY
$0.11 - $9.94 $27,392 - $2.48 Million
249,027 Added 311.37%
329,004 $3.26 Million
Q1 2022

May 16, 2022
BUY
$9.69 - $9.81 $774,977 - $784,574
79,977 New
79,977 $785,000

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IBERE PHARMACEUTICALS

IBER Quotes by TradingView
  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Saba Capital Management, L.P. Portfolio

Follow Saba Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saba Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Saba Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email